[Early diagnosis of neurometabolic diseases by tandem mass spectrometry. Acylcarnitine profile from cord blood].
BACKGROUND
Tandem mass spectrometry (MS/MS) provides a multi-analyte technology for the detection of disorders characterised by the presence of abnormal concentrations of metabolites related to neurological deterioration. It has been recently recommended the use of this technique for early diagnosis of inherited metabolic diseases using cord blood.


OBJECTIVE
To draw the attention to the inherited metabolic diseases detected by tandem mass spectrometry and to establish reference values for acylcarnitines in cord blood.


METHODS
One hundred and thirty cord blood specimens from full-term and normal birth weight children (78 males and 52 females) were analysed by MS/MS.


CONCLUSIONS
Reference values for acylcarnitines from cord blood by MS/MS as a tool for the diagnosis of some neurometabolic diseases are provided. No statistical significant difference between sexes was found. We reviewed the literature related to the diagnosis of inherited metabolic diseases, with emphasis in fatty acid mitochondrial beta-oxidation using MS/MS.
Osorio
J H
JH
Universidad de Caldas, Manizales, Colombia. josheno@yahoo.com
Pourfarzam
M
M
D002331:Carnitine / Q000031:analogs & derivatives* / Q000097:blood*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D013058:Mass Spectrometry; D008659:Metabolic Diseases / Q000097:blood* / Q000150:complications / Q000175:diagnosis*; D009422:Nervous System Diseases / Q000097:blood* / Q000150:complications / Q000175:diagnosis*; D012016:Reference Values; D013997:Time Factors
C116917:acylcarnitine; D002331:Carnitine